The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

For Big Pharma CEOs, compensation can swing drastically year to year — from base salary to bonus incentives to stock options ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...

Dame Emma Walmsley prides herself on her tenacity. It is something the GSK chief says she inherited from her late father, a ...

GSK boss Walmsley (left) received £10.6m in salary and bonuses in 2024 while Blanc (right), head of insurance group Aviva, ...

The pharmaceutical firm has followed several companies which have dropped diversity goals amid pressure from President Donald ...